Highlights Teladoc Health, Inc.

Equities

TDOC

US87918A1051

Real-time Estimate Cboe BZX Other stock markets 10:28:37 2024-04-29 am EDT			5-day change	1st Jan Change
13.11 ^USD	+0.77%		-2.89%	-40.07%

02:18pm	Truist Securities Cuts Teladoc's Price Target to $15 From $17, Maintains Hold Rating	MT
Apr. 26	UBS Adjusts Teladoc Price Target to $16 From $20, Maintains Neutral Rating	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Earnings Flash (TDOC) TELADOC HEALTH Reports Q1 Revenue $646.1M, vs. Street Est of $637.4M	Apr. 25	MT
Teladoc Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Teladoc Health, Inc. Provides Earnings Guidance for the Second Quarter and Full Year of 2024	Apr. 25	CI
Teladoc Chief Executive Leaves, Chief Financial Officer Mala Murthy Named Acting CEO	Apr. 05	MT
Teladoc Health Seeks M&A	Mar. 13	CI
Health Care Down on a Mixed Growth View -- Health Care Roundup	Feb. 21	DJ
Teladoc Shares Fall After Q4 Results, Guidance	Feb. 21	MT
Teladoc's Q4 Net Loss Narrows as Revenue Increases; Issues Q1, 2024 Guidance	Feb. 21	MT
Stocks to Watch : Palo Alto Networks, SolarEdge, Teladoc Health	Feb. 20	DJ
Teladoc Guides For Q1 Loss of $0.55-$0.45 on Revenue of $630-$645 Million, vs CIQ Analyst Consensus of GAAP Loss of $0.43/Share, Non-GAAP Loss of $0.37, on Revenue of $673 Million	Feb. 20	MT
Earnings Flash (TDOC) TELADOC HEALTH Reports Q4 Revenue $660.5M, vs. Street Est of $671.1M	Feb. 20	MT
(TDOC) TELADOC HEALTH Sees Fiscal Year 2024 EPS Range $-1.10 - $-0.80	Feb. 20	MT
Teladoc Health, Inc. Provides Earnings Guidance for the First Quarter and Full Year of 2024	Feb. 20	CI
Teladoc Health, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 20	CI
Teladoc Health Q3 Net Loss Narrows, Revenue Rises; Q4 Outlook Set; 2023 Net Loss, Revenue Guidance Adjusted	23-10-24	MT
Teladoc Guides For Q4 EPS Loss of $0.33-$0.23 on Revenue of $658-$683 Million, vs CIQ Analyst Consensus of $0.19/Share Loss on Revenue of $687 Million	23-10-24	MT
Earnings Flash (TDOC) TELADOC HEALTH Posts Q3 Revenue $660.2M, vs. Street Est of $663.1M	23-10-24	MT
Teladoc Health, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year Ending December 31, 2023	23-10-24	CI
Teladoc Health, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-24	CI
Teladoc Shares Rise Wednesday After Reporting Narrower Loss, Higher Revenue in Q2	23-07-26	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Teladoc Health, Inc.

Equities

TDOC

US87918A1051

Highlights

Filters